M&A Deal Summary

Bausch Health Acquires Bausch & Lomb

On May 27, 2013, Bausch Health acquired medical products company Bausch & Lomb from Welsh Carson Anderson & Stowe, Warburg Pincus and Lexington Partners for 8.7B USD

Acquisition Highlights
  • This is Bausch Health’s 2nd transaction in the Medical Products sector.
  • This is Bausch Health’s 2nd largest (disclosed) transaction.
  • This is Bausch Health’s 12th transaction in the United States.
  • This is Bausch Health’s 2nd transaction in New York.

M&A Deal Summary

Date 2013-05-27
Target Bausch & Lomb
Sector Medical Products
Buyer(s) Bausch Health
Sellers(s) Welsh Carson Anderson & Stowe
Warburg Pincus
Lexington Partners
Deal Type Add-on Acquisition
Deal Value 8.7B USD

Target

Bausch & Lomb

Rochester, New York, United States
Bausch & Lomb is a manufacturer of ophthalmic products.

Search 200,388 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Bausch Health

Laval, Quebec, Canada

Category Company
Sector Life Science
Employees20,270
Revenue 8.8B USD (2023)
DESCRIPTION

Bausch Health is a multinational specialty pharmaceutical company that develops, manufactures and markets a broad range of pharmaceutical products primarily in the areas of dermatology, neurology, and branded generics. Bausch Health is based in Laval, Quebec.


DEAL STATS #
Overall 24 of 35
Sector (Medical Products) 2 of 6
Type (Add-on Acquisition) 17 of 25
State (New York) 2 of 3
Country (United States) 12 of 22
Year (2013) 3 of 4
Size (of disclosed) 2 of 27
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2013-03-20 Obagi

Long Beach, California, United States

Obagi is a physician-dispensed brand in the dermo-cosmetic space, the highest-growth category in skin care. Obagi's product portfolio includes brands Obagi Nu-Derm®, Condition & Enhance®, Obagi-C® Rx, ELASTIDerm® and CLENZIDerm®.

Buy $360M
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2013-11-01 Valeant Pharmaceuticals Caladryl

India

Valeant Pharmaceuticals Caladryl is an anti-pruritic solution known for dermatosis application for minor skin irritations and itching.

Sell -

Seller(S) 3

SELLER

Welsh Carson Anderson & Stowe

New York, New York, United States

Investor Investor Investor Investor Investor


Category Private Equity Firm
Founded 1979
PE ASSETS 31.0B USD
Size Mega
Type Sector Focused
DESCRIPTION

Welsh Carson Anderson & Stowe (WCAS) is a mega-sized, specialist private equity firm focused on investments in growth-oriented companies operating within the healthcare and technology/tech-enabled services industries. WCAS will consider small and large transactions; including venture investments, growth equity investments, buy-and-build transactions, public-to-private acquisitions, and corporate carve-outs. The Firm prefers control situations and generally seeks opportunities in the US. Welsh Carson Anderson & Stowe was formed in 1979 and is based in New York City.


DEAL STATS #
Overall 40 of 75
Sector (Medical Products) 4 of 6
Type (Add-on Acquisition) 26 of 44
State (New York) 4 of 6
Country (United States) 39 of 72
Year (2013) 1 of 3
Size (of disclosed) 1 of 33
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2013-01-03 GetWellNetwork

Bethesda, Maryland, United States

GetWellNetwork, Inc. is a provider of patient engagement solutions that help health care providers engage, educate and empower patients along the care continuum. Our patient-centered platform, delivered across multiple technology platforms including mobile devices, computers and televisions, enables providers to implement a revolutionary care delivery model called Interactive Patient Care™ to improve performance and patient outcomes. The company further extends the value of existing IT investments by integrating seamlessly with electronic medical record and patient portal applications.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2013-07-13 Triple Point Technology

Westport, Connecticut, United States

Triple Point Technology is a global provider of cloud and on-premise Commodity Management software that delivers advanced analytics for optimizing end-to-end commodity and energy value chains.

Sell $900M
SELLER

Warburg Pincus

New York, New York, United States

Investor Investor Investor Investor Investor


Category Private Equity Firm
Founded 1966
PE ASSETS 83.0B USD
Size Mega
Type Sector Agnostic
DESCRIPTION

Warburg Pincus is a mega-sized, global private equity firm focused on investment opportunities across North America, Asia, and Europe. Warburg will consider investing at various company stages, from early-stage opportunities to distressed situations. Warburg Pincus is organized by industry groups. Verticals include financial services, healthcare, technology, media & telecommunications, energy, consumer & industrial, and real estate. Within financial services, Warburg will consider asset/wealth managers, banks, exchanges, financial technology, insurance, transaction processing, private banking, and specialty/consumer finance. Within healthcare, specific areas of interest include medical devices, healthcare services, and biotech/pharmaceuticals. Within technology/media/communications, Warburg targets software, media/internet/information, financial technology, telecom, business services, and systems/semiconductors. Within energy, specific areas of interest include oil/gas exploration, power generation/transmission, and alternative energy. Warburg Pincus raised its first fund in 1966 and is based in New York City.


DEAL STATS #
Overall 84 of 251
Sector (Medical Products) 8 of 12
Type (Add-on Acquisition) 32 of 90
State (New York) 5 of 11
Country (United States) 53 of 137
Year (2013) 6 of 21
Size (of disclosed) 2 of 63
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2013-05-08 Webster Bank

Stamford, Connecticut, United States

Webster Bank is a bank holding company for Webster Bank. Webster provides consumer and business banking, mortgage, financial planning, and trust and investment services. Webster Bank was founded in 1935 and is based in Waterbury, Connecticut.

Sell -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2013-05-29 Primerica

Duluth, Georgia, United States

Primerica is a distributor of financial products to middle income households in North America. Primerica representatives educate their Main Street clients about how to better prepare for a more secure financial future by assessing their needs and providing appropriate solutions through term life insurance. Primerica was founded in 1927 and is based in Duluth, Georgia.

Sell -
SELLER

Lexington Partners

New York, New York, United States

Category Private Equity Firm
Founded 1994
PE ASSETS 55.0B USD
Size Mega
Type Sector Agnostic
DESCRIPTION

Lexington Partners is a private investment firm with approximately $33 billion in committed capital for private equity investing. Lexington Partners focuses its activity on secondary investments, equity co-investments, and fund investments. Lexington's primary business is its secondary private equity group, which seeks to provide liquidity for private equity fund interests. Lexington's co-investment group looks to invest $10 to $100 million alongside private equity sponsors in a variety of sectors. Lexington Partners was formed in 1994 and is based in New York City.


DEAL STATS #
Overall 4 of 5
Sector (Medical Products) 1 of 1
Type (Add-on Acquisition) 3 of 3
State (New York) 1 of 1
Country (United States) 3 of 3
Year (2013) 1 of 1
Size (of disclosed) 1 of 2
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2012-06-19 Alliance Boots

Zug, Switzerland

Alliance Boots GmbH is an international pharmacy-led health and beauty group. Alliance Boots' pharmacy-led health and beauty retail businesses now operate more than 3,330 health and beauty retail stores in 11 countries and its pharmaceutical wholesale businesses supply medicines, other healthcare products and related services to more than 170,000 pharmacies, doctors, health centers and hospitals in 21 countries.

Sell -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2014-02-28 Mec3

Rimini, Italy

Mec3 is a developer, manufacturer and marketer of ingredients for gelato, pastry and other foods. Mec3 was founded in 1984 and is based in Rimini, Italy.

Buy -